Tau Positron Emission Tomography (PET) Longitudinal Substudy Associated With: Study of Crenezumab Versus Placebo in Preclinical Presenilin1 (PSEN1) E280A Mutation Carriers in the Treatment of Autosomal-Dominant Alzheimer’s Disease

Alzheimer disease type 3

Gut Microbiome and Blood Indices in Patients With AD and Their Spousal Caregivers China Longitudinal Aging and Cognitive Impairment Study Study of Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of NIO752 in Early Alzheimer’s Disease Participants Multi-Center Development of a Novel Diagnostic Test for Alzheimer’s Disease The Chinese Familial Alzheimer’s Network Tau Positron Emission Tomography (PET) Longitudinal Substudy Associated With: Study of Crenezumab Versus Placebo in Preclinical Presenilin1 (PSEN1) E280A Mutation Carriers in the Treatment of Autosomal-Dominant Alzheimer’s Disease